Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion type Assertion NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_head.
- NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion description "[However, when determining merlin and ezrin in ovarian carcinoma cells, we have observed that both merlin and ezrin could be over-expressed simultaneously in some ovarian cancer (OVCA) cell lines and OVCA ascites cells, suggesting that merlin could be an oncoprotein rather than a tumor suppressor protein in certain OVCA cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_provenance.
- NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion evidence source_evidence_literature NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_provenance.
- NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion SIO_000772 16824698 NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_provenance.
- NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion wasDerivedFrom befree-20140225 NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_provenance.
- NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_assertion wasGeneratedBy ECO_0000203 NP306369.RARok367WDHRIuCPCj1ceyTvLddNNDYW28wFMwmpuFRy4130_provenance.